Genmab — Juli 2017
-
Der var i øvrigt lige mange arbejdsdage i jun og maj
-
Netop.
-
Er der nogen, der kender noget til fejlkilderne mellem Symphony's data og aktuelle omsætningstal?
-
Umiddelbart er dara et medikament med (relativt) lav omsætning og et massivt kliniske program bag sig - men som Vester noterede, så var Q1 omsætningen spot on
-
Har denne været omtalt før?? “Conventional therapies used to treat MGRS don’t always work, which leaves the patient with few options,” said Sanjiv Anand, MD, MS, transplant nephrologist with the Intermountain Medical Center Kidney Transplantation Program, and lead author of the study. “After trying all the conventional therapies with our patient, we decided to go one step further and move forward with an off-label use of a relatively new drug called Daratumumab.”
-
“Dr. Anand's work demonstrates the efficacy of Daratumumab in the setting of PGNMID,” added Titte Srinivas, MD, FAST, medical director of the Intermountain Medical Center Kidney Transplantation Program. “The ability of Daratumumab to directly target plasma cells affords a new way to treat plasma cell disorders with a positive impact on kidney function
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind